Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Payables (2024 - 2026)

Updated

Nervgen Pharma's Payables came in at $3.02 million for Q2 2026, down 28.5% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Payables (2024 - 2026) Analysis & Trends

At the end of FY2025, Nervgen Pharma's Payables was $3.4 million, down 1.2% from FY2024.

  • Going back by year, Payables was $3.44 million in FY2024 (+37.3%) and $2.51 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Payables since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.17 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 7.17 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -25.19 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 3.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.02 Mn
Mar 31, 2026 4.22 Mn
Dec 31, 2025 3.40 Mn
Dec 31, 2024 3.44 Mn
Jan 1, 2024 2.51 Mn
API Access

Nervgen Pharma Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=NGEN&period=max&api_key=YOUR_API_KEY